Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value ($000): $1,342,913 (100.0% shares, 0.0% debt)

Holdings (42)

INTERMUNE INC 16.9%
Value ($000) $226,669 Shares 5,134,058 Est. Cost $19.48 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 8.0%
Value ($000) $107,412 Shares 1,213,828 Est. Cost $69.22 Unrealized +38.9%
CYBERONICS INC 8.0%
Value ($000) $107,146 Shares 1,715,430 Est. Cost $52.15 Unrealized
CUBIST PHARMACEUTICALS INC 7.9%
Value ($000) $106,609 Shares 1,526,916 Est. Cost $57.96 Unrealized
AUXILIUM PHARMACEUTICALS INC 7.3%
Value ($000) $97,384 Shares 4,854,631 Est. Cost $17.45 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 4.2%
Value ($000) $56,959 Shares 915,587 Est. Cost $63.05 Unrealized -4.2%
ABIOMED INC 4.1%
Value ($000) $55,496 Shares 2,207,489 Est. Cost $21.31 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.9%
Value ($000) $52,430 Shares 3,240,424 Est. Cost $7.72 Unrealized +72.6%
STAA STAAR SURGICAL CO 3.3%
Value ($000) $43,672 Shares 2,599,553 Est. Cost $8.10 Unrealized +103.2%
SEQUENOM INC 2.8%
Value ($000) $37,966 Shares 9,810,442 Est. Cost $3.91 Unrealized
CLOVIS ONCOLOGY INC 2.8%
Value ($000) $37,903 Shares 915,321 Est. Cost $45.26 Unrealized
KYTHERA BIOPHARMACEUTICALS I 2.7%
Value ($000) $36,450 Shares 949,959 Est. Cost $38.49 Unrealized
AMAG PHARMACEUTICALS INC 2.5%
Value ($000) $33,453 Shares 1,614,536 Est. Cost $22.29 Unrealized
ANACOR PHARMACEUTICALS INC 2.2%
Value ($000) $29,460 Shares 1,661,612 Est. Cost $6.24 Unrealized
CELLADON CORP 1.8%
Value ($000) $23,522 Shares 1,468,300 Est. Cost $11.92 Unrealized
ALIMERA SCIENCES INC 1.6%
Value ($000) $21,737 Shares 3,634,984 Est. Cost $4.88 Unrealized
QUESTCOR PHARMACEUTICALS INC 1.5%
Value ($000) $20,255 Shares 218,995 Est. Cost $48.32 Unrealized
NPS PHARMACEUTICALS INC 1.5%
Value ($000) $20,137 Shares 609,300 Est. Cost $31.13 Unrealized
INSM INSMED INC 1.4%
Value ($000) $19,223 Shares 962,101 Est. Cost $13.66 Unrealized +8.4%
RIGEL PHARMACEUTICALS INC 1.4%
Value ($000) $18,804 Shares 5,180,101 Est. Cost $3.43 Unrealized
MOMENTA PHARMACEUTICALS INC 1.3%
Value ($000) $17,579 Shares 1,455,176 Est. Cost $14.44 Unrealized
SHIRE PLC 1.1%
Value ($000) $15,001 Shares 63,700 Est. Cost $233.03 Unrealized
ARIAD PHARMACEUTICALS INC 1.1%
Value ($000) $14,496 Shares 2,275,603 Est. Cost $6.82 Unrealized
CELGENE CORP 1.0%
Value ($000) $13,327 Shares 155,180 Est. Cost $87.10 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.0%
Value ($000) $13,265 Shares 3,971,576 Est. Cost $3.07 Unrealized -23.6%
EXAS EXACT SCIENCES CORP 1.0%
Value ($000) $13,244 Shares 777,676 Est. Cost $12.83 Unrealized +7.3%
GILD GILEAD SCIENCES INC 1.0%
Value ($000) $12,801 Shares 154,400 Est. Cost $54.09 Unrealized -0.0%
ALLERGAN INC 0.9%
Value ($000) $12,505 Shares 73,900 Est. Cost $169.22 Unrealized
PRTA PROTHENA CORP PLC 0.9%
Value ($000) $12,042 Shares 534,018 Est. Cost $22.48 Unrealized +11.2%
OREXIGEN THERAPEUTICS INC 0.9%
Value ($000) $11,936 Shares 1,931,324 Est. Cost $6.46 Unrealized
QLT INC 0.9%
Value ($000) $11,663 Shares 1,887,208 Est. Cost $4.40 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.7%
Value ($000) $9,907 Shares 176,788 Est. Cost $52.19 Unrealized -0.3%
MEDIVATION INC 0.7%
Value ($000) $9,473 Shares 122,900 Est. Cost $77.08 Unrealized
INTUITIVE SURGICAL INC 0.6%
Value ($000) $7,577 Shares 18,400 Est. Cost $411.79 Unrealized
GERN GERON CORP 0.3%
Value ($000) $4,043 Shares 1,259,500 Est. Cost $2.85 Unrealized -26.8%
REVANCE THERAPEUTICS INC 0.2%
Value ($000) $3,117 Shares 91,669 Est. Cost $31.50 Unrealized
XOMA CORP DEL 0.2%
Value ($000) $2,868 Shares 624,900 Est. Cost $4.20 Unrealized
AVEO PHARMACEUTICALS INC 0.2%
Value ($000) $2,197 Shares 1,200,800 Est. Cost $2.50 Unrealized
HYPERION THERAPEUTICS INC 0.1%
Value ($000) $1,636 Shares 62,700 Est. Cost $22.00 Unrealized
SOPHIRIS BIO INC 0.0%
Value ($000) $656 Shares 292,900 Est. Cost $3.88 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value ($000) $591 Shares 123,686 Est. Cost $6.71 Unrealized -9.1%
BIOSPECIFICS TECHNOLOGIES CO 0.0%
Value ($000) $302 Shares 11,184 Est. Cost $27.00 Unrealized